(52) analyzed IL-36α concentrations in the serum of patients with EOC – endometrioid ovarian cancer, serous ovarian cancer, mucinous carcinoma, and mixed-type ovarian cancer, whereas in our study we analyzed the concentration of this interleukin in material from patients with serous ovarian cancer, which indicates that the function of IL-36 may vary depending on the type of ovarian cancer, which is an interesting observation. Here, IL36A is linked to ovarian serous adenocarcinoma.